Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.22.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.22.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
GS.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCFORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCFNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
CH.1.1.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
XBB.1.5.109ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.109ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.109NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HK.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCZORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCZNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used